1. Home
  2. ELBM vs SCLX Comparison

ELBM vs SCLX Comparison

Compare ELBM & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electra Battery Materials Corporation

ELBM

Electra Battery Materials Corporation

HOLD

Current Price

$0.57

Market Cap

64.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.20

Market Cap

55.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELBM
SCLX
Founded
2011
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.7M
55.1M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ELBM
SCLX
Price
$0.57
$5.20
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.15
N/A
AVG Volume (30 Days)
317.4K
37.5K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
$28.71
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$4.20
52 Week High
$8.70
$34.27

Technical Indicators

Market Signals
Indicator
ELBM
SCLX
Relative Strength Index (RSI) 46.20 33.73
Support Level $0.56 $4.20
Resistance Level $0.60 $7.77
Average True Range (ATR) 0.03 0.30
MACD -0.00 0.03
Stochastic Oscillator 15.23 16.67

Price Performance

Historical Comparison
ELBM
SCLX

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: